Latest filing published 08 Oct 2026 for Biolife Solutions INC. Read the official filing
Todd Berard (senior executive) discloses dealings in Biolife Solutions Inc to SEC (Form 4). Between 13 May 2021 and 6 October 2026, the trades on record add up to 84 filings.
On the market, this insider has only sold: 56 sales, €1.6M in total. Besides market trades, the filings include 15 share grants and 12 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The record was last updated on 8 October 2026 with a transaction in Biolife Solutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 84 declarations